Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Harmony Biosciences Holdings Inc.
HRMY | US
30.80
USD-1.28
-3.99%
HRMY | US
Loading StockChartView...
About Harmony Biosciences Holdings Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
30.80
Open
31.80
High
32.13
Low
30.77
Harmony Biosciences Holdings Inc. a commercial-stage pharmaceutical company focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant) a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II Inc. and changed its name to Harmony Biosciences Holdings Inc. in February 2020. Harmony Biosciences Holdings Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting Pennsylvania.
View LessHRMY | US
Risk
41.6
Sharpe
0.04
Luna's Score
48/100
Recommendation
Hold
Luna says (HRMY | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
Weakness based on declining price with high volume
High Short-term Volatility
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
50.1%1 month
41.6%3 months
49.0%6 months
41.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
18.16
Fwd. PE
8.79
Price to book
3.69
Debt to equity
0.41
Debt to assets
0.26
Ent. to EBITDA
8.69
Ent. to rev.
2.78
PEG
-
Other Fundamentals
EBITDA
202.50M
MarketCap
1.75B
MarketCap(USD)
1.75B
Div. yield
-
Op. margin
12.36
Erngs. growth
-64.30
Rev. growth
28.80
Ret. on equity
22.47
Short ratio
17.70
Short perc.
67.07
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
6.55
Range1M
8.54
Range3M
12.47
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.06
Price X volume
27.41M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.69 | 0.53 | Expensive |
| Ent. to Revenue | 2.78 | 3,967.00 | Cheaper |
| PE Ratio | 18.16 | 41.03 | Cheaper |
| Price to Book | 3.69 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 48.99 | 72.80 | Lower Risk |
| Debt to Equity | 0.41 | -1.23 | Expensive |
| Debt to Assets | 0.26 | 0.25 | Par |
| Market Cap | 1.75B | 3.66B | Emerging |
